Modeling how memory CD8 T cells can elicit post-treatment control of HIV infection
- 1Universite Paris Cite, INSERM, IAME, F-75018 Paris, France
Abstract
While most people living with HIV suffer progressive disease following cessation of antiretroviral therapy, a small fraction elicits lasting post-treatment control. Understanding the mechanisms underlying this control is key to devising effective HIV remission strategies. Although recent studies implicate memory CD8 T cells, how these cells establish lasting viremic control remains unknown. Here, we combine mathematical modeling and analysis of data from SIV-infected non-human primates to elucidate the underlying mechanisms. We recognized that sustained antigenic stimulation leads to heritable epigenetic remodeling of the CD8 T cell pool, impairing memory cell survivability. Antiretroviral therapy rapidly suppresses viremia, thereby arresting antigenic stimulation and preserving memory potential. The greater this preservation is, the better would be the memory recall response following viral rebound post-treatment. Our mathematical model based on this hypothesis predicts that post-treatment control is an alternative steady state to progressive infection, realized by strong memory-driven recall responses. Our model fits longitudinal virological data spanning the pre-, during-, and post-antiretroviral treatment phases of infection, and recapitulates the outcomes of progressive disease and long-term remission realized, the latter predominantly with early treatment initiation. It shows, consistently with data, that memory CD8 T cells could drive post-treatment control independently of the size of the latent reservoir, explaining how such control may be realized more widely than estimated with prevalent hypotheses. Our model further explains the existence of a window of treatment initiation times that maximizes the chances of post-treatment control. Finally, model predictions inform interventions targeting memory CD8 T cells for HIV remission.
Related
- Modeling decision dynamics disentangles working memory, cognitive control and reinforcement learning and reveals clinical differences
- Vesicle architecture licenses antigen-specific memory T cell immunity after mucosal immunization with infection-derived vesicles
- In vivo measurements of fascia lata effective mechanics combined to a memory fiber–recruitment–viscoelastic modeling approach
- Modeling congenital cytomegalovirus infection in human inner ear organoids
- Inherited maternal memory T cells protect offspring from respiratory viral infection through disease tolerance
BibTeX
@misc{vemparala2026modeling,
title = {{Modeling how memory CD8 T cells can elicit post-treatment control of HIV infection}},
author = {B. Vemparala and C. Passaes and D. Desjardins and V. Monceaux and J. Lemaitre and A. Melard and C. Charre and M. Gourves and N. Dimant and N. Dereuddre-Bosquet and A. Barrail-Tran and H. Gouget and C. Guillaume and F. Relouzat and O. Lambotte and M. Muller-Trutwin and C. Rouzioux and V. Avettand-Fenoel and R. Le Grand and A. Saez-Cirion and N. M. Dixit and J. Guedj},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.01.748582},
url = {https://www.biorxiv.org/content/10.64898/2026.09.01.748582v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Modeling how memory CD8 T cells can elicit post-treatment control of HIV infection
AU - B. Vemparala
AU - C. Passaes
AU - D. Desjardins
AU - V. Monceaux
AU - J. Lemaitre
AU - A. Melard
AU - C. Charre
AU - M. Gourves
AU - N. Dimant
AU - N. Dereuddre-Bosquet
AU - A. Barrail-Tran
AU - H. Gouget
AU - C. Guillaume
AU - F. Relouzat
AU - O. Lambotte
AU - M. Muller-Trutwin
AU - C. Rouzioux
AU - V. Avettand-Fenoel
AU - R. Le Grand
AU - A. Saez-Cirion
AU - N. M. Dixit
AU - J. Guedj
PY - 2026
DA - 2026/09/01
PB - bioRxiv
DO - 10.64898/2026.09.01.748582
UR - https://www.biorxiv.org/content/10.64898/2026.09.01.748582v1
AB - While most people living with HIV suffer progressive disease following cessation of antiretroviral therapy, a small fraction elicits lasting post-treatment control. Understanding the mechanisms underlying this control is key to devising effective HIV remission strategies. Although recent studies implicate memory CD8 T cells, how these cells establish lasting viremic control remains unknown. Here, we combine mathematical modeling and analysis of data from SIV-infected non-human primates to elucidate the underlying mechanisms. We recognized that sustained antigenic stimulation leads to heritable epigenetic remodeling of the CD8 T cell pool, impairing memory cell survivability. Antiretroviral therapy rapidly suppresses viremia, thereby arresting antigenic stimulation and preserving memory potential. The greater this preservation is, the better would be the memory recall response following viral rebound post-treatment. Our mathematical model based on this hypothesis predicts that post-treatment control is an alternative steady state to progressive infection, realized by strong memory-driven recall responses. Our model fits longitudinal virological data spanning the pre-, during-, and post-antiretroviral treatment phases of infection, and recapitulates the outcomes of progressive disease and long-term remission realized, the latter predominantly with early treatment initiation. It shows, consistently with data, that memory CD8 T cells could drive post-treatment control independently of the size of the latent reservoir, explaining how such control may be realized more widely than estimated with prevalent hypotheses. Our model further explains the existence of a window of treatment initiation times that maximizes the chances of post-treatment control. Finally, model predictions inform interventions targeting memory CD8 T cells for HIV remission.
ER -